NanoVibronix develops innovative ultrasound therapy devices based on its proprietary therapeutic ultrasound technology.
Our products employ small, disposable transducers that transmit low frequency, low intensity ultrasound acoustic waves. These devices address a range of clinical applications helping eliminate pain, repair and regenerate tissue in musculoskeletal / vascular structures and decrease
bioﬁlm formation on urinary catheters thus reducing risk of Catheter Associated Urinary Tract Infections (CAUTI).
Due to their effectiveness, size and ease of use, these products help promote patient independence and enable cost-effective home-based care.
For more information about our ultrasound therapy devices, make sure to browse our site to read more about us.
Due to the COVID pandemic, critically ill patients are at the greatest risk, especially when compromised by comorbidities, such as CAUTI. UroShield has been proven to reduce the incidence of CAUTI and as a result, has the potential to reduce readmissions into acute care facilities.
NanoVibronix is appealing to regulatory agencies proposing to increase use of the UroShield and PainShield in order to reduce burden on the healthcare system as well as reduce comorbidities related to COVID-19. Read more…
Targeted therapeutic ultrasound – that uniquely generates and delivers localized, low frequency, low intensity therapeutic ultrasound through a self-adhering patch, placed on or next to the treated area.
Patch based ultrasound device intended to facilitate expedited tissue regeneration and wound healing by increase of local capillary perfusion and tissue oxygenation.
Ultrasound based device that dramatically reduces bacterial colonization and bioﬁlm on urinary catheters, thereby reducing risk for catheter associated urinary tract infection (CAUTI)